These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 16893693)

  • 21. Effect of everolimus-eluting stents in different vessel sizes (from the pooled FUTURE I and II trials).
    Tsuchiya Y; Lansky AJ; Costa RA; Mehran R; Pietras C; Shimada Y; Sonoda S; Cristea E; Negoita M; Dangas GD; Moses JW; Leon MB; Fitzgerald PJ; Müller R; Störger H; Hauptmann KE; Grube E
    Am J Cardiol; 2006 Aug; 98(4):464-9. PubMed ID: 16893698
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of late incomplete stent apposition: a comparison among bare-metal stents, intracoronary radiation and sirolimus-eluting stents.
    Miyazawa A; Tsujino I; Ako J; Shimada Y; Courtney BK; Sakurai R; Nakamura M; Okura H; Waseda K; Honda Y; Fitzgerald PJ
    J Invasive Cardiol; 2007 Dec; 19(12):515-8. PubMed ID: 18180522
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Baseline and 9 months IVUS analysis of the bifurcation-dedicated biolimus A9-eluting Axxess stent system: the DIVERGE IVUS substudy.
    Buysschaert I; Sanidas E; Hasegawa T; Koo BK; Honda Y; Fitzgerald PJ; Verheye S
    Catheter Cardiovasc Interv; 2014 Dec; 84(7):1062-70. PubMed ID: 24478226
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vascular response to sirolimus-eluting stents delivered with a nonaggressive implantation technique: comparison of intravascular ultrasound results from the multicenter, randomized E-SIRIUS, and SIRIUS trials.
    Hoffmann R; Guagliumi G; Musumeci G; Reimers B; Petronio AS; Disco C; Amoroso G; Moses JW; Fitzgerald PJ; Schofer J; Leon MB; Breithardt G
    Catheter Cardiovasc Interv; 2005 Dec; 66(4):499-506. PubMed ID: 16273564
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical outcome following aleatory implantation of paclitaxel-eluting or sirolimus-eluting stents in complex coronary lesions.
    Cosgrave J; Agostoni P; Ge L; Iakovou I; Chieffo A; Biondi-Zoccai GG; Sangiorgi GM; Montorfano M; Michev I; Airoldi F; Carlino M; Corvaja N; Bonizzoni E; Colombo A
    Am J Cardiol; 2005 Dec; 96(12):1663-8. PubMed ID: 16360354
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of intravascular ultrasonic imaging with versus without incomplete stent apposition at follow-up after drug-eluting stent implantation.
    Qian J; Zhang F; Wu H; Fan B; Ge L; Ge J
    Int J Cardiovasc Imaging; 2008 Feb; 24(2):133-9. PubMed ID: 17703294
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk of late-acquired incomplete stent apposition after drug-eluting stent versus bare-metal stent. A meta-analysis from 12 randomized trials.
    Sanchez-Recalde A; Moreno R; Barreales L; Rivero F; Galeote G; Jimenez-Valero S; Calvo L; López de Sá E; López-Sendón JL
    J Invasive Cardiol; 2008 Aug; 20(8):417-22. PubMed ID: 18688067
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Coronary restenosis elimination with a sirolimus eluting stent: first European human experience with 6-month angiographic and intravascular ultrasonic follow-up.
    Rensing BJ; Vos J; Smits PC; Foley DP; van den Brand MJ; van der Giessen WJ; de Feijter PJ; Serruys PW
    Eur Heart J; 2001 Nov; 22(22):2125-30. PubMed ID: 11686669
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intravascular ultrasound assessment of postprocedural incomplete stent apposition.
    Kume T; Waseda K; Ako J; Sakata K; Yamasaki M; Shimohama T; Tsujino I; Hasegawa T; Fitzgerald PJ; Honda Y
    J Invasive Cardiol; 2012 Jan; 24(1):13-6. PubMed ID: 22210583
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Incomplete stent apposition after implantation of paclitaxel-eluting stents or bare metal stents: insights from the randomized TAXUS II trial.
    Tanabe K; Serruys PW; Degertekin M; Grube E; Guagliumi G; Urbaszek W; Bonnier J; Lablanche JM; Siminiak T; Nordrehaug J; Figulla H; Drzewiecki J; Banning A; Hauptmann K; Dudek D; Bruining N; Hamers R; Hoye A; Ligthart JM; Disco C; Koglin J; Russell ME; Colombo A;
    Circulation; 2005 Feb; 111(7):900-5. PubMed ID: 15710761
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Simultaneous kissing drug-eluting stent technique for percutaneous treatment of bifurcation lesions in large-size vessels.
    Sharma SK
    Catheter Cardiovasc Interv; 2005 May; 65(1):10-6. PubMed ID: 15810018
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of acute and long-term results and underlying mechanisms from sirolimus-eluting stent implantation for the treatment of in-stent restenosis and recurrent in-stent restenosis in patients in whom intracoronary radiation failed as assessed by intravascular ultrasound.
    Schiele TM; Rieber J; König A; Leibig M; Erhard I; Theisen K; Siebert U; Klauss V
    Am J Cardiol; 2004 Oct; 94(7):917-21. PubMed ID: 15464677
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of asymmetric stent expansion on neointimal hyperplasia following sirolimus-eluting stent implantation.
    Kaneda H; Ako J; Honda Y; Terashima M; Morino Y; Yock PG; Popma JJ; Leon MB; Moses JW; Fitzgerald PJ
    Am J Cardiol; 2005 Nov; 96(10):1404-7. PubMed ID: 16275187
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Coronary restenosis after sirolimus-eluting stent implantation: morphological description and mechanistic analysis from a consecutive series of cases.
    Lemos PA; Saia F; Ligthart JM; Arampatzis CA; Sianos G; Tanabe K; Hoye A; Degertekin M; Daemen J; McFadden E; Hofma S; Smits PC; de Feyter P; van der Giessen WJ; van Domburg RT; Serruys PW
    Circulation; 2003 Jul; 108(3):257-60. PubMed ID: 12860901
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of coronary remodeling after sirolimus-eluting stent implantation by serial three-dimensional intravascular ultrasound.
    Degertekin M; Regar E; Tanabe K; Lemos P; Lee CH; Smits P; de Feyter P; Bruining N; Sousa E; Abizaid A; Ligthart J; Serruys PW
    Am J Cardiol; 2003 May; 91(9):1046-50. PubMed ID: 12714144
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vascular effects of sirolimus-eluting versus bare-metal stents in diabetic patients: three-dimensional ultrasound results of the Diabetes and Sirolimus-Eluting Stent (DIABETES) Trial.
    Jiménez-Quevedo P; Sabaté M; Angiolillo DJ; Costa MA; Alfonso F; Gómez-Hospital JA; Hernández-Antolín R; Bañuelos C; Goicolea J; Fernández-Avilés F; Bass T; Escaned J; Moreno R; Fernández C; Macaya C;
    J Am Coll Cardiol; 2006 Jun; 47(11):2172-9. PubMed ID: 16750681
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of vascular response to zotarolimus-eluting stent versus sirolimus-eluting stent: intravascular ultrasound results from ENDEAVOR III.
    Miyazawa A; Ako J; Hongo Y; Hur SH; Tsujino I; Courtney BK; Hassan AH; Kandzari DE; Honda Y; Fitzgerald PJ;
    Am Heart J; 2008 Jan; 155(1):108-13. PubMed ID: 18082499
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of Paclitaxel-eluting versus sirolimus-eluting stents on coronary restenosis in Korean diabetic patients.
    Kim MH; Hong SJ; Cha KS; Park HS; Chae SC; Hur SH; Gwon HC; Bae JH; Lim DS
    J Interv Cardiol; 2008 Jun; 21(3):225-31. PubMed ID: 18341520
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Percutaneous coronary revascularization using a trilayer metal phosphorylcholine-coated zotarolimus-eluting stent.
    Abizaid A; Lansky AJ; Fitzgerald PJ; Tanajura LF; Feres F; Staico R; Mattos L; Abizaid A; Chaves A; Centemero M; Sousa AG; Sousa JE; Zaugg MJ; Schwartz LB
    Am J Cardiol; 2007 May; 99(10):1403-8. PubMed ID: 17493469
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Delayed strut fracture of sirolimus-eluting stent: a significant problem or an occasional observation?
    Min PK; Yoon YW; Moon Kwon H
    Int J Cardiol; 2006 Jan; 106(3):404-6. PubMed ID: 16337054
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.